Izotropic Corporation (IZO.CN)
Chart Events
Performance Outlook
| Previous Close | 0.3900 |
| Open | 0.4200 |
| Bid | 0.4050 x 0 |
| Ask | 0.4150 x 0 |
| Day's Range | 0.4050 - 0.4200 |
| 52 Week Range | 0.2850 - 0.8600 |
| Volume | |
| Avg. Volume | 40,284 |
| Market Cap | 21.52M |
| Beta (5Y Monthly) | 2.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1240 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Izotropic's Technical & Scientific Team Members Advocate for Commercialization of Breast CT Technology
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, releases statements from select key members of its technical and scientific teams advocating for the commercialization and clinical capabilities of breast CT techno
- Newsfile
Izotropic Releases First Video of IzoView
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, is pleased to release the first video showcasing the completed engineering of IzoView. This video is the first in a series of presentations, interviews, and demonstra
- Newsfile
Izotropic Reports Board Meeting Results
Vancouver, British Columbia--(Newsfile Corp. - January 4, 2023) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, reports the results of the board meeting held December 29, 2022. The Board of Directors is pleased to report the strengthening and refocussing of Izotropic's manageme
